FDA Inspection
Intermax Pharmaceuticals, Inc.Intermax Pharmaceuticals, Inc. – FDA Inspection, Feb 3, 2009
Record Details
This FDA Inspection record concerns Intermax Pharmaceuticals, Inc., with an inspection on February 3, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 3, 2009
- Product Type
- Drugs
View Company Profile
ID · 2623c505-7353-42a9-8fa3-489cbcce9049
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 560581
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Intermax Pharmaceuticals, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 28, 2011 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Intermax Pharmaceuticals, Inc.
- FDA Inspection 768948 - 2012-02-21
- FDA Inspection 754912 - 2011-11-28
- FDA Inspection 696893 - 2010-11-08
- FDA Inspection 659964 - 2010-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.